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Primary gastric non-Hodgkin’s lymphoma (NHL) is a co-morbidity that can be observed during the clinical course
of acquired immunodeficiency syndrome (AIDS). We evaluated the prevalence, clinical-evolutive aspects and form
of endoscopic presentation of primary gastric NHL associated with AIDS. Two hundred and forty-three HIV patients
were submitted to upper digestive endoscopy, with evaluation of clinical, endoscopic and histological data. A CD4
count was made by flow cytometry and viral load was determined in a branched-DNA assay. Six cases (five men;
mean age: 37 years; range: 29-46 years) of primary gastric NHL were detected. The median CD4 count was 140 cells/
mm3 and the median viral load was 40,313 copies/mL. Upper digestive endoscopy revealed polypoid (in four patients)
ulcero-infiltrative (two patients) and ulcerated (two patients) lesions and combined polypoid and ulcerated lesions
(two patients). Histology of the gastric lesions demonstrated B cell NHL (four patients) and T cell NHL (two
patients). Five of the six patients died of complications related to gastric NHL. We concluded that primary gastric
NHL is an important cause of mortality associated with AIDS.
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The immunosuppression triggered by acquired
immunodeficiency syndrome (AIDS) predisposes to a series
of opportunistic infections and neoplasias, such as Kaposi’s
sarcoma and non-Hodgkin’s lymphoma (NHL) [1,2].
Individuals infected with human immunodeficiency virus
(HIV) are at high risk to develop NHL; i.e., they are about 50
times more likely to develop NHL than the HIV-negative
population [3,4].
NHL is a common complication in the late phase of HIV
infection, with a high frequency of involvement of the
gastrointestinal tract (GIT) [2,5]. The occurrence of primary
GIT NHL has been associated with reduced survival of HIV-
infected patients [3,6]. Highly active antiretroviral therapy
(HAART) seems to have a protective effect against the onset
of NHL associated with HIV [4,7].
We evaluated the prevalence of primary gastric NHL in
243 HIV-infected patients submitted to upper digestive
endoscopy (UDE) from August 1995 to May 2005 in the
Service of Digestive Endoscopy of the Special Unit for the
Treatment of Infectious Diseases of the University Hospital,
Faculty of Medicine of Ribeirão Preto, to assess the clinical-
evolutive aspects and forms of endoscopic presentation of
primary gastric NHL associated with AIDS. Clinical data were
obtained concerning age, sex, risk factors for HIV acquisition,
symptoms related to gastric involvement by NHL, use of
HAART, survival time, and mortality data. CD4 counts were
made by flow cytometry and HIV load was determined by
the branched DNA (bDNA) assay six months before the
UDE exam. The form of presentation and the location of
NHL in the stomach were determined by videogastroscopy
[Pentax Model EG 2901 (9.8 mm)].
Fragments of the gastric lesions obtained by endoscopy
were evaluated by two experienced pathologists of the
service. The material was stained with hematoxylin-eosin
and examined by immunohistochemistry with markers for B
and T cells. Primary gastric NHL was detected in six of the
243 HIV-positive patients (2.5%) submitted to UDE in our
service.
Five of these patients were male; patient age ranged from
29 to 46 years (mean: 37 years) The risk factors for HIV infection
detected in patients with primary gastric NHL were sexual for
four of the six cases and intravenous drug use for two patients.
Median time between diagnosis of HIV and the appearance of
NHL was 42 months (range: 8-96 months). Only three patients
were using HAART before the diagnosis of NHL.
Median CD4 count was 140 cells/mm³ (range: 55 to 326
cells/mm³) and median viral load was 40,313 copies/mL (range:
50 to 1,200,000 copies/mL), measured in blood collected up to
six months before UDE. The main complaints reported by the
patients with NHL that led to the indication of UDE were
epigastric pain in four cases, nausea and vomiting in two
cases, and hematemesis in one case.
All six patients with gastric NHL presented lesions in the
gastric region. Concomitant lesions in the fundus were found
in three cases and there was involvement of the antrum in two
cases. The UDE revealed a polypoid lesion in four cases
(Figure 1a), ulcero-infiltrative lesions in two cases (Figure 1b),
and ulcerated lesions in two cases (Figure 1c), with combined
polypoid and ulcerated lesions observed in two cases (Figure
1d). Histology of the gastric lesions demonstrated B cell NHL
in four cases and T cell NHL in two.
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Five patients died of complications related to gastric
lymphoma. The median survival time after the diagnosis of NHL
was 185 days (range: 11 to 600 days). None of the patients who
died had received specific chemotherapy. The most common
causes of death were bacterial pneumonia in three cases and
acute renal failure in two cases. Only one patient was still alive
at the time we prepared this article, with a survival time of two
years and 10 months. This patient had been submitted to three
sessions of specific chemotherapy and continues to be clinically
followed up, with no indication of cure of lymphoma thus far.
Non-Hodgkin’s Lymphoma Associated with AIDS
Figure 1. Endoscopic view of the stomach showing a polypoid lesion (1a), an ulcero-infiltrative aspect (1b), an ulcerated lesion
(1c), and a combined polypoid and ulcerated lesion (1d), compatible with non-Hodgkin’s lymphoma.
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Lymphomas are common tumors in HIV-infected patients
and, together with Kaposi’s sarcoma, are responsible for
approximately 95% of the neoplasias associated with AIDS
[6,8]. Gastrointestinal tract (GIT) involvement by NHL is
frequent in HIV-positive individuals, occurring in 15% to 75%
of all cases [1,2,9-13]. In this population, the GIT sites most
frequently involved are the stomach (24% of cases), the small
bowel (10% of cases), and the colon and rectum (7% of cases)
[2,5,6]. The frequency distribution of GIT involvement by NHL
in immunocompetent patients is similar, even more frequent in
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the stomach (50% to 80% of cases) and rarely affecting the
small intestine, colon and perianal region [2,5,14]. In our study,
among the 243 HIV-positive patients evaluated by UDE, six
(2.5%) had primary gastric NHL. All six patients had
involvement of the gastric body, with involvement of the
fundus in three cases and also of the antrum in two cases.
Involvement of the gastrointestinal tract by NHL frequently
causes specific symptoms, the most common being abdominal
pain, weight loss, and gastrointestinal bleeding. In our series,
the main complaints of the patients were epigastric pain,
nausea and vomiting. Hematemesis occurred in only one case.
AIDS-associated NHL are usually high-grade B-cell
lymphomas; most of them are of extranodal origin [1,2]. Our
histological findings revealed B cell NHL in four of the six
cases and T cell NHL in two cases.
There are reports that the prognosis of gastrointestinal
NHL is poor in patients with AIDS, with a survival of
approximately six months [1,13,15]. We found a similar mean
survival of about 185 days. A combination of chemotherapeutic
agents is the treatment of choice for NHL. However, the rate
of response to chemotherapy is normally low, usually less
than 40% [2,16,17].
The presence of high CD4 counts and of polyclonal
lymphomas, and the absence of Epstein-Bar virus infection
and of AIDS-defining disease before diagnosis are associated
with improved survival of these patients [2,10,11,16-19]. We
conclude that NHL is a common complication occurring in the
late phase of HIV infection, with a high frequency of stomach
involvement. Despite all the advances in diagnosis and therapy,
the occurrence of primary gastrointestinal NHL associated
with HIV has been associated with reduced patient survival,
being an important cause of AIDS-associated mortality.
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